Congleton Jon insider trades
Congleton Jon has filed 28 Form 4s with the SEC that we hold, for Mineralys Therapeutics, Inc. (MLYS) (Chief Executive Officer, Director), Immunic, INC. (IMUX) (Director) and Avalyn Pharma Inc. (AVLN) (Director). Across all of them we count 4 purchases worth $105.6K and 29 sales worth $19.3M reported on Form 4. In the last 12 months: 0 purchases ($0) and 18 sales ($16.8M). The largest single trade was a sale of 112,275 shares of Mineralys Therapeutics, Inc. worth $5.1M, dated 2025-11-11. Of 1 sale filed since we began reading the 10b5-1 checkbox, 1 (100%) was marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2023-02-13 and the latest 2026-10-02.
Mineralys Therapeutics, Inc. (MLYS)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-08-11 | P, purchase reported on Form 4 | 2,000 | $25.8K | 2023-08-11 |
| 2023-08-17 | P, purchase reported on Form 4 | 2,250 | $27.2K | 2023-08-21 |
| 2023-09-06 | P, purchase reported on Form 4 | 2,250 | $27.2K | 2023-09-08 |
| 2023-11-22 | P, purchase reported on Form 4 | 4,250 | $25.4K | 2023-11-27 |
| 2024-06-12 | S, sale reported on Form 4 | 16,607 | $212.1K | 2024-06-14 |
| 2024-06-13 | S, sale reported on Form 4 | 39,961 | $509.1K | 2024-06-14 |
| 2024-06-14 | S, sale reported on Form 4 | 16,229 | $203.2K | 2024-06-14 |
| 2024-06-17 | S, sale reported on Form 4 | 17,766 | $217.6K | 2024-06-20 |
| 2024-06-18 | S, sale reported on Form 4 | 16,607 | $199.1K | 2024-06-20 |
| 2024-06-20 | S, sale reported on Form 4 | 14,940 | $175.2K | 2024-06-20 |
| 2024-07-11 | S, sale reported on Form 4 | 15,746 | $210.1K | 2024-07-12 |
| 2024-10-11 | S, sale reported on Form 4 | 15,271 | $206.5K | 2024-10-15 |
| 2025-01-13 | S, sale reported on Form 4 | 18,333 | $166.1K | 2025-01-15 |
| 2025-04-11 | S, sale reported on Form 4 | 15,319 | $186.7K | 2025-04-15 |
| 2025-07-11 | S, sale reported on Form 4 | 15,884 | $230.5K | 2025-07-15 |
| 2025-10-13 | S, sale reported on Form 4 | 1,552 | $66.8K | 2025-10-15 |
| 2025-10-13 | S, sale reported on Form 4 | 13,548 | $577.6K | 2025-10-15 |
| 2025-11-11 | S, sale reported on Form 4 | 32,850 | $1.5M | 2025-11-13 |
| 2025-11-11 | S, sale reported on Form 4 | 112,275 | $5.1M | 2025-11-13 |
| 2025-11-11 | S, sale reported on Form 4 | 29,207 | $1.3M | 2025-11-13 |
| 2025-11-11 | S, sale reported on Form 4 | 4,000 | $174.0K | 2025-11-13 |
| 2025-11-11 | S, sale reported on Form 4 | 8,862 | $375.0K | 2025-11-13 |
| 2025-11-11 | S, sale reported on Form 4 | 12,806 | $533.2K | 2025-11-13 |
| 2026-01-12 | S, sale reported on Form 4 | 9,119 | $293.7K | 2026-01-13 |
| 2026-01-12 | S, sale reported on Form 4 | 7,117 | $235.9K | 2026-01-13 |
| 2026-03-31 | S, sale reported on Form 4 | 19,364 | $493.8K | 2026-04-02 |
| 2026-03-31 | S, sale reported on Form 4 | 453 | $12.3K | 2026-04-02 |
| 2026-03-31 | S, sale reported on Form 4 | 55,183 | $1.5M | 2026-04-02 |
| 2026-04-13 | S, sale reported on Form 4 | 15,730 | $422.0K | 2026-04-15 |
| 2026-06-30 | S, sale reported on Form 4 | 17,000 | $455.9K | 2026-06-30 |
| 2026-06-30 | S, sale reported on Form 4 | 58,000 | $1.5M | 2026-06-30 |
| 2026-07-13 | S, sale reported on Form 4 | 10,700 | $291.4K | 2026-07-15 |
| 2026-09-30 | S, sale reported on Form 4 | 75,000 | $1.9M | 2026-10-02 |
Immunic, INC. (IMUX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Avalyn Pharma Inc. (AVLN)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1644975) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms